Bilialliance (tablet )

Under registration

  Imecromone it is a natural active principle reproduced by original synthesis. By definition it is a true choleric

Formula:

Imecromone 300 mg

Indications:

• Dyspepsia secondary to insufficient biligenetic function.
• Spasm of the sphincter of Oddi and biliary tract.
• Adjuvant in gallbladder lithiasis, cholecystitis and after-effects of cholecystectomy.
• Adjuvant in small and medium hepatic insufficiency.
• is used in the treatment of biliary dyskinesias and dyspepsia secondary to insufficient biligenetic function.

Administration and Dosage

1-2 coated tablets 2-3 times a day.

Presentation:

pack with 30 FC tablet

Allianeuro   (ampoule)

Under registration

Vitamin B12 injection

Formula:

Each ampoule COBAMAMIDE contains:  Cobamamide 5000 mcg  Each ampoule with dissolvent contains: Apyrogenic distilled water for injections 2 ml.

Indications:

• Pernicious, macrocytic and hemolitic anemia.
• Anemia educing owing to chronic diseases and postoperative anemia.
• Anemia educing at oncological diseases and liver diseases.

Administration and Dosage

Children: 1 ampoule I.M. every other day. At desirable result, 1 ampoules once a week during the term administered by the doctor.

Adults: 1 ampoule I.M. per day. At desirable result. 1-2 ampoules during the term administered by the doctor.

Presentation:

Allianeuro is supplied in pack with 3 frozen-dried ampoules and 3 ampoules with aqueous solution.

Alliafloxacin(tablet )

Under registration

  Lascufloxacin it is a novel 8-methoxy fluoroquinolone antibiotic showed a broad spectrum of activity against various clinical isolates

Formula:

Lascufloxacin Hydrochloride 75 mg

Indications:

• treatment of respiratory tract and ear, nose and throat infections including community-acquired pneumonia and otorhinolaryngological infections
• Pharyngitis, stomatitis, tonsillitis (including peritonsillitis and peritonsillar abscess), acute bronchitis, pneumonia, secondary infection of chronic respiratory disease, middle ear infection, sinusitis

Administration and Dosage

Once daily dose

Presentation:

Pack with 30 FC tablet

Phalcodinum(syrup)

Under registration

Phalcodinum  is amazing formula which suppress the cough and allergic symptoms in short time

Formula:

Pholcodine 5 mg, ephedrine 8 mg ,Chlorpheniramine 2 mg

Indications:

For the symptomatic relief of dry or painful cough. It also relieves nasal congestion in colds and hay fever.

Administration and Dosage

10 ML 3time daily

Presentation:

Bottle with 120 ml

Dustoliance (syrup)

Under registration

Dustoliance  increase hemoglobin rate rapidly after oral take with renal impairment patients

Formula:

Enarodustat 4 mg

Indications:

• Enarodustat has the potential for renal anemia treatment
• Anti-anemic, Hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor

Administration and Dosage

For patients with CKD not on dialysis and on peritoneal dialysis;
The recommended starting dose for adult patients is 4 mg taken orally once
daily before a meal or at bedtime. Thereafter, the dose should be adjusted
as appropriate depending on the patient’s condition. The maximum dose is
8 mg per dose.

Presentation:

Pack with 30 FC tablet

Rosuliance (SG Capsule)

Under registration

Rosuliance control LDL and triglyceride in a save way

Formula:

Rosuvastatin 5 mg; Omega3 fatty acid 1000 mg

Indications:

• Improves endothelial function in patients subjects with dyslipidemia and endothelial dysfunction.
• Treat combined dyslipidemia (type IIb) in high risk of coronary heart disease (CHD) patients whose LDL cholesterol adequately controlled with Rosuvastatin

Administration and Dosage

Once daily capsule.

Presentation:

pack with 30 SG capsule

Armonikos ®(vial)

Under registration

Armonikos vial  used in adults and children 6 years of age and older with obesity due to the genetic conditions

Formula:

Setmelanotide 10 mg /mL (1-mL multidose vial)

Indications:

• For long-term weight management in patients with obesity owing to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency
• Reduced weight and hunger for people with obesity due to POMC or PCSK1 deficiency

Administration and Dosage

Starting dose: 2 mg SC qDay for 2 weeks subcutaneous

2 mg qDay not tolerated: Reduce to 1 mg SC qDay; if 1 mg qDay tolerated and additional weight loss desired, titrate to 2 mg qDay

2 mg qDay tolerated and additional weight loss desired: Increase to 3 mg SC qDay; if not tolerated, maintain dose at 2 mg qDay

Presentation:

Armonikos is supplied in pack with multi dose Subcutaneous injection vial